€29.6 -0.2 -0.7%
Last Trade - 4:36pm
Market Cap | £1.02bn |
Enterprise Value | £1.35bn |
Revenue | £419.7m |
Position in Universe | 387th / 1046 |
Jan 19 (Reuters) - BIOTEST AG BIOG.DE : * DGAP-ADHOC: BIOTEST AG: ALL CONDITIONS MET FOR CREAT TAKEOVER OF BIOTEST * FOREIGN TRADE APPROVAL HAS BEEN GIVEN BY U.S. COMMITTEE ON FOREIGN INVESTMENT IN UNITED STATES (CFIUS) * LAST REMAINING CONDITION HAS BEEN MET FOR TAKEOVER OFFER BY TIANCHENG (GERMANY) PHARMACEUTICAL HOLDINGS AG * THUS UNSOLICITED TAKEOVER BID ANNOUNCED ON MAY 18, 2017 FOR SHARES OF BIOTEST AG BECOMES EFFECTIVE * IN CONNECTION WITH APPROVAL, BIOTEST HAS SIGNED AN AGREEMENT FOR SALE OF ITS U.S. COMPANIES Source text for Eikon: ID:nEQ31pLkha Further company coverage: BIOG.DE (Gdynia Newsroom) ((gdynia.newsroom@thomsonreuters.com; +48 58 722 0920;))